Lifecore Biomedical, Inc. LFCR Income Statement
| Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $23.19M-25.4% | $31.11M-14.6% | $36.44M+3.7% | $35.15M+8.0% | $32.56M+31.8% | ||
| $18.73M-19.7% | $23.32M+3.8% | $22.46M-11.2% | $25.31M+17.8% | $21.48M+11.2% | ||
| $4.46M-42.7% | $7.79M-44.3% | $13.98M+42.0% | $9.85M-11.2% | $11.08M+106% | ||
| 19.2%-5.8pp | 25%-13.3pp | 38.4%+10.4pp | 28%-6.0pp | 34%+12.2pp | ||
| $1.22M-38.0% | $1.96M-6.7% | $2.1M+2.8% | $2.05M+6.3% | $1.92M-12.0% | ||
| $7.92M-11.0% | $8.9M-0.9% | $8.98M-10.0% | $9.98M-10.3% | $11.12M-24.8% | ||
| -$4.67M-52.3% | -$3.07M— | —— | -$9.03M-361% | -$1.96M+83.1% | ||
| -20.1%-10.3pp | -9.9%— | —— | -25.7%-19.7pp | -6%+40.9pp | ||
| —— | —— | —— | —— | —— | ||
| $110K0.0% | $110K— | —— | $333K+210% | -$304K-49.8% | ||
| -$14.94M-54.7% | -$9.66M-767% | -$1.11M+92.5% | -$14.78M-126% | -$6.53M+59.8% | ||
| $43K-87.1% | $333K+909% | $33K+513% | -$8K-119% | $43K+272% | ||
| -$14.98M-49.9% | -$9.99M-771% | -$1.15M+92.2% | -$14.77M-125% | -$6.57M+59.5% | ||
| -64.6%-32.5pp | -32.1%-29.0pp | -3.1%+38.9pp | -42%-21.8pp | -20.2%+45.5pp | ||
| -$0.43-48.3% | -$0.29-867% | -$0.03+92.9% | -$0.42-68.0% | -$0.25+52.8% | ||
| -$2.36M-117% | -$1.09M-236% | $800K+112% | -$6.95M-8,280% | $85K+101% | ||
| -10.2%-6.7pp | -3.5%-5.7pp | 2.2%+22.0pp | -19.8%-20.0pp | 0.3%+39.1pp | ||
| -$4.67M-52.3% | -$3.07M-175% | -$1.11M+87.7% | -$9.03M-361% | -$1.96M+83.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lifecore Biomedical, Inc.'s revenue?
- Lifecore Biomedical, Inc. (LFCR) generated $125.9M in revenue over the trailing twelve months, down 3.8% year over year.
- Is Lifecore Biomedical, Inc. profitable?
- Lifecore Biomedical, Inc. is not currently profitable: it reported a net loss of $40.9M over the trailing twelve months, a -30.0% net margin.
- What are Lifecore Biomedical, Inc.'s profit margins?
- Gross margin is 31.3% and operating margin is -14.5%, with a -30.0% net margin.
- What is Lifecore Biomedical, Inc.'s earnings per share?
- Lifecore Biomedical, Inc.'s diluted EPS over the trailing twelve months is $-1.17.
- Where does Lifecore Biomedical, Inc.'s income statement data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
